SARS Coronavirus
Researchers publish new studies and findings in the area of SARS coronavirus
Published in TB and Outbreaks Week, August 2nd, 2005
Study 1: Researchers suggest possibility for an effective immunoprophylaxis strategy for a SARS coronavirus outbreak.
According to a study from the United States, "In this report, the antiviral activity of 80R immunoglobulin G1 (IgG1), a human monoclonal antibody against severe acute respiratory syndrome coronavirus (SARS-CoV) spike (S) protein that acts as a viral entry inhibitor in vitro, was investigated in vivo in a mouse model. When 80R IgG1 was given prophylactically to mice at doses therapeutically achievable in humans, viral...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- HIV/AIDS Epidemiology
High HIV transmission rates in Africa due to high rates of other untreated STIs - Methicillin-Resistant Staphylococcus Aureus
Community-associated MRSA outbreak occurred in maternity unit - SARS Coronavirus
Molecular interactions for adaptation of SARS-CoV to human cells described - Tuberculosis
Nose-only apparatus developed to study airborne delivery of M. tuberculosis - Tuberculosis Peritonitis
TB peritonitis diagnosis overlooked in patients with abdominal pain and symptoms - Anthrax
Assay detects antibody-mediated neutralization of anthrax protective antigen - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
